Acurx Pharmaceuticals, Inc. Shares Authorized
Acurx Pharmaceuticals, Inc. (ACXP) had Shares Authorized of 250.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares Authorized 250.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 250.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 250.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 250.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 250.00M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 250.00M shares 10-Q · filed 2026-05-11 | |
| 2025-12-31 | 250.00M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 250.00M shares 10-Q · filed 2025-11-12 | |
| 2025-09-22 | 250.00M shares 10-Q · filed 2026-08-13 | |
| 2025-09-21 | 200.00M shares 10-K · filed 2026-03-12 | |
| 2025-09-16 | 200.00M shares 10-Q · filed 2026-08-13 | |
| 2025-06-30 | 200.00M shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 200.00M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 200.00M shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 200.00M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 200.00M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 200.00M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 200.00M shares 10-K · filed 2025-03-17 | |
| 2023-09-30 | 200.00M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 200.00M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 200.00M shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 200.00M shares 10-K · filed 2024-03-15 | |
| 2022-09-30 | 200.00M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 200.00M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 200.00M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 200.00M shares 10-K · filed 2023-03-15 | |
| 2021-09-30 | 200.00M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 200.00M shares 10-Q · filed 2021-08-13 | |
| 2021-06-23 | 250.00M shares 10-Q · filed 2026-05-11 | 200.00M shares 10-Q · filed 2022-11-10 |
| 2020-12-31 | 200.00M shares 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |